Factors associated with ejaculatory and orgasmic dysfunction in men with erectile dysfunction: analysis of clinical trials involving the phosphodiesterase type 5 inhibitor tadalafil.


Abstract

EjD and OD occurred at baseline in more than one in three men enrolled in tadalafil trials.

Even men with mild ED reported EjD or OD. Further studies are warranted to better understand the impacts of EjD and OD on male sexuality and quality of life.


Full Text


Subjects


Similar articles

Authors


Publication date

2012-03-14


Journal

BJU international
BJU Int (1464-410X)

Journal topics


Language

Eng.


Copyright

BJU international

Department of Urology and Reproductive Medicine, Weill Cornell Medical College, New York, NY 10065, USA. dap2013 [at] med.cornell.edu


Release reference

BJU Int. 2012 Apr;109(7):1060-7



Related books


Español | English

© Galenicom 1999-2013